ISIN | CH0137596661 |
---|---|
Valor Number | 13759666 |
Bloomberg Global ID | BBG0025YH505 |
Fund Name | Bellevue Healthcare Strategy I |
Fund Provider |
Bellevue Asset Management AG
Zürich, Switzerland Phone: +41 44 267 67 00 E-Mail: info@bellevue.ch Web: www.bellevue.ch |
Fund Provider | Bellevue Asset Management AG |
Representative in Switzerland | |
Distributor(s) |
Zürcher Kantonalbank Zürich Phone: +41 44 293 93 93 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | Special conditions apply to the issue of units |
Redemption Condition | Special conditions apply to the redemption of units |
Investment Strategy *** | N/A |
Peculiarities |
Current Price * | 3,335.43 CHF | 04.09.2025 |
---|---|---|
Previous Price * | 3,325.00 CHF | 03.09.2025 |
52 Week High * | 3,713.92 CHF | 30.01.2025 |
52 Week Low * | 3,079.28 CHF | 11.04.2025 |
NAV * | 3,335.43 CHF | 04.09.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 120,058,515 | |
Unit/Share Assets *** | 58,412,582 | |
Trading Information SIX |
YTD Performance | -4.80% |
31.12.2024 - 04.09.2025
31.12.2024 04.09.2025 |
---|---|---|
1 month | +3.55% |
04.08.2025 - 04.09.2025
04.08.2025 04.09.2025 |
3 months | +1.15% |
04.06.2025 - 04.09.2025
04.06.2025 04.09.2025 |
6 months | -6.14% |
04.03.2025 - 04.09.2025
04.03.2025 04.09.2025 |
1 year | -9.17% |
04.09.2024 - 04.09.2025
04.09.2024 04.09.2025 |
2 years | -3.06% |
05.09.2023 - 04.09.2025
05.09.2023 04.09.2025 |
3 years | -7.20% |
06.09.2022 - 04.09.2025
06.09.2022 04.09.2025 |
5 years | -2.77% |
04.09.2020 - 04.09.2025
04.09.2020 04.09.2025 |
Equity Participation Rate in % | 94.80 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | 1.20 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date | 04.09.2025 |
Thermo Fisher Scientific Inc | 3.49% | |
---|---|---|
Galderma Group AG Registered Shares | 3.35% | |
Vertex Pharmaceuticals Inc | 3.25% | |
AbbVie Inc | 3.22% | |
Eli Lilly and Co | 3.14% | |
Stryker Corp | 3.06% | |
Abbott Laboratories | 3.04% | |
Boston Scientific Corp | 3.03% | |
McKesson Corp | 3.01% | |
Sandoz Group AG Registered Shares | 2.95% | |
Last data update | 31.07.2025 |
TER | 0.81% |
---|---|
TER date | 30.09.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.80% |
Ongoing Charges *** | |
SRRI ***
|
|
SRRI date *** | 31.08.2025 |